For the Inventor, By the Inventor

Enter assignee name

Zurich, Switzerland

Metriopharm Ag

USPTO Granted Patents = 8

EPO Patents = 13

Forward Citations = 5

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Wolfgang Brysch (8 out of 12 patents)

Jörg Von Wegerer (6 out of 9 patents)

Josef Breu (5 out of 19 patents)

4. Thomas Martin (5 out of 5 patents)

5. Astrid Kaiser (4 out of 4 patents)

6. Beate Ludescher (4 out of 4 patents)

7. Michael Niedermaier (3 out of 3 patents)

8. Juliane Fleissner (2 out of 2 patents)

9. Gerrit Maass (2 out of 2 patents)

10. Wolfgang Milius (2 out of 2 patents)

11. Ingo Saar (1 out of 4 patents)

12. Claudia Van Laak (1 out of 1 patent)

13. Maliha Shah (1 out of 1 patent)

14. David Kosel (1 out of 1 patent)

15. Sara Schumann (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12616695 - Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseases (2026-05-05),

2. 12122753 - Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione (2024-10-22),

3. 11203575 - Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione (2021-12-21),

4. 11111218 - Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione (2021-09-07),

5. 11007192 - Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis (2021-05-18),

6. 10258620 - Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form (2019-04-16),

7. 9079863 - Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms (2015-07-14),

8. 8772294 - Crystalline forms for 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms (2014-07-08),

Company Overview

Metriopharm AG is a Swiss-based biopharmaceutical company focused on developing and commercializing innovative treatments for chronic inflammatory and autoimmune diseases. With a strong pipeline of novel compounds and a commitment to research and development, Metriopharm is dedicated to bringing new therapies to patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#83 in Zurich

#1,223 in Switzerland

Zurich, Switzerland

Metriopharm Ag

Forward Citations = 5

17 inventors:

Wolfgang Brysch (8 out of 12 patents)

Jörg Von Wegerer (6 out of 9 patents)

Josef Breu (5 out of 19 patents)

4. Thomas Martin (5 out of 5 patents)

5. Astrid Kaiser (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Metriopharm Ag. Retrieved from https://idiyas.com/company/metriopharm-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…